Characterization of Carbapenem-Resistant K. Pneumoniae Isolated from Intensive Care Units of Zagazig University

Nessma Hessin Mohamed Gandor1, Ghada El-Sayed Amr1, Sahar Mohamed Saad Eldin Algammal2

  • 1Department of Clinical Pathology, Faculty of Medicine, Zagazig University, Alsharquia 44519, Egypt.

Insights

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a growing threat. The NDM gene was most common in Egyptian ICU isolates, highlighting a significant public health burden.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Carbapenem-resistant Klebsiella pneumoniae (CRKP) infections are a critical concern, particularly in intensive care units (ICUs).
  • Carbapenems are often the last-resort antibiotics for treating these severe nosocomial infections.
  • The increasing prevalence of CRKP necessitates understanding local resistance patterns.

Purpose of the Study:

  • To characterize carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates from patients in Zagazig University Hospitals (ZUHs) ICU, Egypt.
  • To identify the prevalence of key carbapenemase-encoding genes (blaNDM, blaOXA-48, blaKPC) in these isolates.

Main Methods:

  • Isolation and identification of Klebsiella pneumoniae from ICU patients.
  • Molecular detection of carbapenemase-encoding genes, including blaNDM, blaOXA-48, and blaKPC, using appropriate laboratory techniques.

Main Results:

  • The study identified CRKP isolates from the ZUHs ICU.
  • The blaNDM gene was the most predominant carbapenemase-encoding gene, found in 56.2% of isolates.
  • blaOXA-48 and blaKPC genes were present in 41.0% and 32.4% of isolates, respectively.

Conclusions:

  • The high prevalence of carbapenemase-encoding genes, particularly blaNDM, in CRKP isolates from Egyptian ICUs is a significant public health challenge.
  • This situation contributes to substantial morbidity, mortality, and increased healthcare costs in developing countries like Egypt.
  • Urgent strategies are needed to combat the spread of CRKP and manage infections effectively.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...